Opticyte is transforming care for the leading causes of organ failure, including sepsis, with real-time measurements.
Opticyte has raised $285K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in July 2025.
Opticyte's investors include National Science Foundation, National Institutes of Health, StarFish Medical, MedTech Innovator, SWAN Venture Fund.
Opticyte is headquartered in Seattle, United States.
Opticyte is transforming care for the leading causes of organ failure, including sepsis, with real-time measurements.
Opticyte is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Opticyte — Funding & Investors." VCBacked, July 1, 2025, https://www.vcbacked.co/company/opticyte. Accessed July 19, 2026.
VCBacked. (2025). Opticyte — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/opticyte
{{cite web |title=Opticyte — Funding & Investors |url=https://www.vcbacked.co/company/opticyte |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated